<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2020.89010</article-id><article-id pub-id-type="publisher-id">JBM-102845</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Morphofunctional Properties of Human Platelets, Treated with Low Doses of Hydrogen Peroxide
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maksim</surname><given-names>S. Makarov</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maya</surname><given-names>V. Storozheva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Laboratory of Biotechnologies and Transfusiology, N. V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>09</month><year>2020</year></pub-date><volume>08</volume><issue>09</issue><fpage>125</fpage><lpage>130</lpage><history><date date-type="received"><day>10,</day>	<month>August</month>	<year>2020</year></date><date date-type="rev-recd"><day>12,</day>	<month>September</month>	<year>2020</year>	</date><date date-type="accepted"><day>15,</day>	<month>September</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We studied morphofunctional properties of human platelets, treated with low doses of hydrogen peroxide (H
  <sub>2</sub>O
  <sub>2</sub>). It was shown that platelet incubation with 20 - 75 
  <em>μ</em>M H
  <sub>2</sub>O
  <sub>2</sub> during 24 hours at 20
  &amp;deg;C - 22
  &amp;deg;C did not cause visible structural deficiencies in cells. Platelets maintained their adhesion activity and velocity of degranulation at 20 
  <em>μ</em>M H
  <sub>2</sub>O
  <sub>2</sub>. 30 - 60 μM H
  <sub>2</sub>O
  <sub>2</sub> dose-dependently reduced lamella’s growth and allowed retaining granule bulk inside cytoplasm of spreading platelets. After 1 - 2 hours, the most effect of platelet granules’ stabilization was registered at samples, previously incubated with 60 μM H
  <sub>2</sub>O
  <sub>2</sub>. Adrenalin activation led to rapid degranulation of stabilized platelets, whereas lamella’s growth in activated platelets was low or medium.
 
</p></abstract><kwd-group><kwd>Platelets</kwd><kwd> Granules</kwd><kwd> Lamella</kwd><kwd> Degranulation</kwd><kwd> Stabilization</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) not only provides pathological effects, but also takes part in cell signaling pathways [<xref ref-type="bibr" rid="scirp.102845-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref2">2</xref>]. For example, H<sub>2</sub>O<sub>2</sub> molecules activate cyclooxygenase and protein kinase C, uprising cytoplasmic concentration of Са<sup>2+</sup>-ions, which plays a dramatic role in human platelet activation [<xref ref-type="bibr" rid="scirp.102845-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref4">4</xref>]. High doses of H<sub>2</sub>O<sub>2</sub> (300 - 2000 &#181;М) enhance platelet aggregation [<xref ref-type="bibr" rid="scirp.102845-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref7">7</xref>] and could even stimulate platelet activity without standard agonists [<xref ref-type="bibr" rid="scirp.102845-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref6">6</xref>]. On the other hand, in certain studies, it was found that low doses of H<sub>2</sub>O<sub>2</sub> (40 - 80 &#181;М) reduced platelet aggregation in vitro [<xref ref-type="bibr" rid="scirp.102845-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref8">8</xref>]. One could suppose, low doses of H<sub>2</sub>O<sub>2</sub> stimulate stabilization of platelet granules, blocking their rapid exocytosis under activation. All studies of H<sub>2</sub>O<sub>2</sub>-treated platelets were performed without morphofunctional analysis. Registration of morphofunctional platelets’ properties allows valuing structure integrity of cells and their granules, and allows checking intensity of platelet interaction during cell and substrate contact.</p><p>The aim of this work was to study the influence of low concentrations on human platelets’ morphofunctional properties.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>We used venous donor blood, kept in EDTA. Platelets were extracted by double centrifugation at 300 g and 700 g. In platelet-rich plasma (PRP) total cell concentration estimated 1.0 - 1.6 &#215; 10<sup>9</sup>/ml. Initial clinical 3%-solution of hydrogen peroxide was diluted by phosphate buffer PBS (0.15 М, рН = 7.2) to 100 &#181;М H<sub>2</sub>O<sub>2</sub>, that was measured with PRP in different proportions. In experimental samples final concentration H<sub>2</sub>O<sub>2</sub> was 20 &#181;М, 30 &#181;М, 45 &#181;М, 60 &#181;М and 75 &#181;М, control samples did not contain H<sub>2</sub>O<sub>2</sub>. Experimental and control PRP samples were incubated at 20˚C - 22˚C during 24 hours. To obtain the platelet adhesion, 0.1 - 0.2 ml of control and experimental PRP inflicted on the glass slide, placed in Petri dish and saturated at 37˚C for 1 - 2 hours to stimulate platelet massive adhesion. Then we washed slides with PBS buffer to remove the liquid fraction with non-active cells and studied platelets, spreading on glass. We also researched the possibility of platelet activation after H<sub>2</sub>O<sub>2</sub>-treatment. Platelets were exposed on glass with 45 - 60 &#181;М H<sub>2</sub>O<sub>2</sub> and activated with 1 - 5 mM adrenalin. After adrenalin activation we valued granule volume and intensity of lamella growth.</p><p>Biological integrity of platelets was studied with original morphofunctional method, based on vital fluorochrome dye (trypaflavin and acridine orange) staining [<xref ref-type="bibr" rid="scirp.102845-ref9">9</xref>]. This method allows valuing the number of granules and their attachment inside platelets before and during adhesion and value retaining of granules at different time. Microscopic study was managed with confocal microscope Nikon Eclipse 80i (Nikon, Japan) under objectives &#215;60 and &#215;100. In control and experimental samples we valued content of platelet with granules (%), percentage of cells with lamella during platelet adhesion, % (shows H<sub>2</sub>O<sub>2</sub>-dependent reduction of platelet spreading); granules retain index, % (GRI). Granules retaining analysis based on value of morphofunctional activity rate (MFAR) in control and experimental samples. We registered fluorescence intensity in normal platelets with granules, FIpl.gr. (in points), fluorescence intensity of non-granule cytoplasm in discoid platelets without membrane damage, FIcyt. (in points). In spreading platelets we valued mean MFAR<sub>experiment</sub> to one cell. According to our previous studies, MFAR reduction in normal cell is mainly accompanied with granules exocytosis [<xref ref-type="bibr" rid="scirp.102845-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref9">9</xref>]. Granules retain index, GRI (%) calculated by formula GRI = (MFAR<sub>experiment</sub> − FIcyt): (FIpl.gr. − FIcyt) &#215; 100%. At MFAR<sub>experiment</sub> = FIpl.gr. GRI estimates 100% (all cells retained all their granules), at MFAR<sub>experiment</sub> = FIcyt. GRI estimates 0% (all cells are totally degranulated). Received statistical data processed using the variation statistical methods using the software package “Microsoft Excel 2000”, calculating mean arithmetic values (M) and standard deviation (σ). Differences of values considered reliable in more than 95% significance level.</p></sec><sec id="s3"><title>3. Results</title><p>In non-treated PRP level of FIpl.gr. varied from 65 to 100 points, value of FIcyt—from 25 to 35 points, and mean values were estimated 78.6 &#177; 6.5 and 30.6 &#177; 3.2 points consequently. Mean content of platelets with granules was estimated 52.5% &#177; 4.3%. PRP exposition with 20 - 75 &#181;М H<sub>2</sub>O<sub>2</sub> during 24 hours did not cause any visible changes in platelet structural integrity; in experimental samples FIpl.gr. and FIcyt were similar to control. Studying spreading platelets we found that 20 &#181;М H<sub>2</sub>O<sub>2</sub> had no influence on lamella’s growth and platelet degranulation. After 1 hour adhesion on glass at 20 &#181;М H<sub>2</sub>O<sub>2</sub> platelet effluxed all their granules, formed wide lamellas, were tightly attached, as it took place in control samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)). At the opposite, at 30 &#181;М and higher H<sub>2</sub>O<sub>2</sub> concentrations, a large amount of spreading platelets reduced lamella forming ability and did not contact each other (Figures 1(b)-(e)). At the same time, part of granule bulk retained inside spread platelets (<xref ref-type="table" rid="table1">Table 1</xref>). The highest GRI rate was registered at samples, incubated with 60 &#181;М H<sub>2</sub>O<sub>2</sub>, estimating 59%. 30 - 60 &#181;М H<sub>2</sub>O<sub>2</sub> provided dose-dependent decay of lamella’s growth and platelet degranulation. At 75 &#181;М H<sub>2</sub>O<sub>2</sub> GRI was already lower than at 60 &#181;М H<sub>2</sub>O<sub>2</sub>, and was similar to samples with 45 &#181;М H<sub>2</sub>O<sub>2</sub> (<xref ref-type="table" rid="table1">Table 1</xref>). Such effects depended on H<sub>2</sub>O<sub>2</sub>-incubation time, which ought to be 30 min or more. In samples, incubated during 5 - 10 min, spreading platelets did not maintain their granules and were able to lamella forming.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Morphofunctional analysis of platelet adhesion after previous platelet incubation with low doses of H<sub>2</sub>O<sub>2</sub> during 30 min</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Concentration of H<sub>2</sub>O<sub>2 </sub>in PRP</th><th align="center" valign="middle"  colspan="4"  >Morphofunctional parameters of spreading platelets after 1 hour adhesion at 37˚С</th></tr></thead><tr><td align="center" valign="middle" >Percentage of cells with lamella during platelet adhesion, %</td><td align="center" valign="middle" >Percentage of adhesive cells, bearing 3 or more visible granules, %</td><td align="center" valign="middle" >МFAR of adhesive cells, points</td><td align="center" valign="middle" >Granules retain index, %</td></tr><tr><td align="center" valign="middle" >control (without H<sub>2</sub>O<sub>2</sub>)</td><td align="center" valign="middle" >97.0 &#177; 1.4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >30.7 &#177; 1.2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >20 &#181;М</td><td align="center" valign="middle" >94.8 &#177; 3.2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >31.1 &#177; 1.7</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >30 &#181;М</td><td align="center" valign="middle" >40.0 &#177; 4.0*</td><td align="center" valign="middle" >39.5 &#177; 3.5*</td><td align="center" valign="middle" >49.3 &#177; 6.1*</td><td align="center" valign="middle" >39.1</td></tr><tr><td align="center" valign="middle" >45 &#181;М</td><td align="center" valign="middle" >30.1 &#177; 5.3*</td><td align="center" valign="middle" >59.1 &#177; 4.2*</td><td align="center" valign="middle" >52.3 &#177; 7.9*</td><td align="center" valign="middle" >45.3</td></tr><tr><td align="center" valign="middle" >60 &#181;М</td><td align="center" valign="middle" >20.1 &#177; 2.1*</td><td align="center" valign="middle" >67.0 &#177; 3.8*</td><td align="center" valign="middle" >59.2 &#177; 9.6*</td><td align="center" valign="middle" >59.6</td></tr><tr><td align="center" valign="middle" >75 &#181;М</td><td align="center" valign="middle" >24.2 &#177; 3.1*</td><td align="center" valign="middle" >62.1 &#177; 3.3*</td><td align="center" valign="middle" >51.9 &#177; 6.7*</td><td align="center" valign="middle" >44.4</td></tr></tbody></table></table-wrap><p>*p &lt; 0.05 relative to control.</p><p>Differences between platelets, incubated for 30 min and 1 - 2 hours, were statistically insignificant (р &gt; 0.05). In samples, incubated during 24 hours, mean GRI was in average 1.6 times lower, comparing to samples, incubated for 30 min and 1 - 2 hours (р &lt; 0.05). Obviously 30 min incubation with low concentrations of H<sub>2</sub>O<sub>2</sub> is most effective for platelet granules stabilization. On the other hand, prolongation of platelet adhesion gradually reduced granule content in spreading cells. After 2 hours exposition GRI at 30 &#181;М H<sub>2</sub>O<sub>2 </sub>was 22%, at 45 &#181;М—30%, at 60 &#181;М—51%, at 75 &#181;М—32%. In all experimental samples, avoiding 60 &#181;М H<sub>2</sub>O<sub>2</sub>, GRI in spread platelets after 2 hours was much lower than after 1 hour (р &lt; 0.05). One could conclude that 60 &#181;М H<sub>2</sub>O<sub>2</sub> is most effective for platelet granule stabilization. This effect was reversible: treatment with 1 - 5 mM adrenalin caused total degranulation of previously stabilized platelets at 5 - 10 min. Noticeably, this process was followed by forming of lamellipodias, but their square was markedly lower than in control samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>(f)).</p><p>Hydrogen peroxide significantly affects the balance of oxidizing and reduction processes (redox potential) in living cells and intracellular compartments. Molecules of H<sub>2</sub>O<sub>2</sub> shift redox potential to the area of positive values, stimulating oxidized forms, which are observed during cell aging, apoptosis and other pathophysiological processes [<xref ref-type="bibr" rid="scirp.102845-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref11">11</xref>]. In platelets H<sub>2</sub>O<sub>2</sub> is involved in activation cascade, so hydrogen peroxide may be used to initiate blood clotting in medical practice [<xref ref-type="bibr" rid="scirp.102845-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref13">13</xref>]. The redox potential shifting to negative area turns H<sub>2</sub>O<sub>2</sub> into H<sub>2</sub>O molecules and inhibits the active action of peroxide. However, it is worth emphasizing that high negative levels of redox potential intensively transit -S-S-links into -SH groups in platelet integrin proteins, stimulating platelet adhesion and aggregation [<xref ref-type="bibr" rid="scirp.102845-ref14">14</xref>]. One could suppose, activating of platelet adhesion receptors occurred in reduction medium, that could be delayed by low doses of H<sub>2</sub>O<sub>2</sub> (30 - 75 &#181;М) and blocks platelet rapid spreading. As a result, platelet granules retain inside spreading platelets for a long time. Nevertheless, decay of lamella’s growth may prevent intensive platelet degranulation [<xref ref-type="bibr" rid="scirp.102845-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.102845-ref10">10</xref>], i.e. substrate-contacting platelets without lamella could be activated faster than platelets with wide lamella. Our study showed that 30 - 75 &#181;М H<sub>2</sub>O<sub>2</sub> inhibits growth of platelet lamella, the maximum preservation of platelet granules was similar to observed in experiments, where platelets were incubated with 2.5 &#181;М nanosilver [<xref ref-type="bibr" rid="scirp.102845-ref15">15</xref>]. At the same time, adding of 2.5 - 5.0 &#181;М nanosilver to platelets, which have already begun to spread, retained more than 70% of granules bulk, maintaining lamella’s growth. Thus, suppression of the lamella forming does not mean complete inactivation of platelets. Moreover, the exposure of H<sub>2</sub>O<sub>2</sub>-stabilized platelets with activating doses of adrenaline causes rapid degranulation of platelets. Apparently, the described decay of platelet aggregation under low doses of H<sub>2</sub>O<sub>2</sub> may be primarily due to decrease of platelets contact and inability to form close connections between many cells. Stabilization of platelets with low doses H<sub>2</sub>O<sub>2</sub> is actualized for producing of biotransplants, enriched by platelet components, especially for wound covers in regenerative and emergency medicine.</p></sec><sec id="s4"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s5"><title>Cite this paper</title><p>Makarov, M.S. and Storozheva, M.V. (2020) Morphofunctional Properties of Human Platelets, Treated with Low Doses of Hydrogen Peroxide. Journal of Biosciences and Medicines, 8, 123-130. https://doi.org/10.4236/jbm.2020.89010</p></sec></body><back><ref-list><title>References</title><ref id="scirp.102845-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Buettner, G.R., Wagner, B.A. and Rodgers, V.G.J. (2013) Quantitative Redox Biology: An Approach to Understanding the Role of Reactive Species in Defining the Cellular Redox Environment. Cell Biochemistry and Biophysics, 67, 477-483. https://doi.org/10.1007/s12013-011-9320-3</mixed-citation></ref><ref id="scirp.102845-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Jones, D.P. and Sies, H. (2015) The Redox Code. Antioxidants &amp; Redox Signaling, 23, 734-746. https://doi.org/10.1089/ars.2015.6247</mixed-citation></ref><ref id="scirp.102845-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Loiko, E.N., Samal, A.B. and Shulyakovskaya, S.M. (2003) H2O2-Induced Platelet Aggregation and Increase in Intracellular Ca2+ Concentration Are Blocked by Inhibitors of Intracellular Signaling. Biochemistry, 68, 1210-1216. https://doi.org/10.1023/B:BIRY.0000009135.85883.65</mixed-citation></ref><ref id="scirp.102845-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Offermanns, S. (2006) Activation of Platelet Function through G Protein-Coupled Receptors. Circulation Research, 99, 1293-1304. https://doi.org/10.1161/01.RES.0000251742.71301.16</mixed-citation></ref><ref id="scirp.102845-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Loiko, E.N., Samal, A.B. and Lapsha, V.I. (2004) Disaggregation of Platelet Aggregates Formed by the Action of Thrombin in the Presence of Hydrogen Peroxide. Biochemistry, 69, 602-606. https://doi.org/10.1023/B:BIRY.0000033732.00565.e7</mixed-citation></ref><ref id="scirp.102845-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Vavaev, A.V., Buryachkovskaya, L.I., Uchitel, I.A., Tishchenko, E.G. and Maksimenko, A.V. (2012) Effect of Hydrogen Peroxide and Catalase Derivatives on Functional Activity of Platelets. Bulletin of Experimental Biology and Medicine, 152, 307-312. https://doi.org/10.1007/s10517-012-1515-0</mixed-citation></ref><ref id="scirp.102845-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Vavaev, A.V., Buriachkivskaia, L.I., Tishchenko, E.G., Uchitel, I.A. and Maksimenko, A.V. (2012) Antioxidant and Antiaggregant Effects of Covalent Bienzyme Superoxide Dismutase-Chondroitin Sulfate-Catalase Conjugate in Platelet Interactions. Biomeditsinskaya Khimiya, 58, 300-309. (In Russian) https://doi.org/10.18097/pbmc20125803300</mixed-citation></ref><ref id="scirp.102845-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bulanova, K.J., Sydorenko, V.N., Lobanuk, L.M., Gerasimovich, N.V., Kobjashev, A.A., Zhiv, A.Yu. and Bokut, O.S. (2009) Role of Reactive Oxygen Species in Platelet Functional Activity Changes of Pregnant Women with Gestosis. Medicinsky Zhurnal, 28, 25-29.</mixed-citation></ref><ref id="scirp.102845-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Makarov, M.S., Kobzeva, E.N., Vysochin, I.V., Borovkova, N.V. and Khvatov, V.T. (2014) Morphofunctional Analysis of Human Platelets by Vital Staining. Bulletin of Experimental Biology and Medicine, 156, 409-412. https://doi.org/10.1007/s10517-014-2360-0</mixed-citation></ref><ref id="scirp.102845-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Dayal, S., Wilson, K.M., Motto, D.G., Miller, F.J.Jr., Chauhan, A.K. and Lentz, S.R. (2013) Hydrogen Peroxide Promotes Aging-Related Platelet Hyperactivation and Thrombosis. Circulation, 127, 1308-1316. https://doi.org/10.1161/CIRCULATIONAHA.112.000966</mixed-citation></ref><ref id="scirp.102845-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pushkina, T.A., Tokayev, E.S., Popova, T.S. and Borodina, E.N. (2016) Superoxide Dismutase as a Component of Antioxidant Therapy: Current State of the Issue and Prospects. A Literature Review. Sklifosovsky Journal of Emergency Medical Care, 4, 42-47. (In Russian)</mixed-citation></ref><ref id="scirp.102845-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Korotkevich, A.G., Antonov, U.A., Serebrennikova, E.V., Leontiev, A.S. and Kuznetsov, V.V. (2012) Effectiveness of Infiltration Endoscopic Hemostasis in Patients with Upper Gastrointestinal Bleeding. Neotlozhnaya Medicinskaya Pom, 3, 16-20. (In Russian)</mixed-citation></ref><ref id="scirp.102845-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Medvedev, I.N., Plotnikov, A.V. and Kumova, T.A. (2008) Rapid Normalization of Platelet Hemostasis in Patients with Arterial Hypertension and Metabolic Syndrome. Russian Journal of Cardiology, 2, 43-46. (In Russian)</mixed-citation></ref><ref id="scirp.102845-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Murphy, D.D., Reddy, E.C., Moran, N. and O’Neill, S. (2014) Regulation of Platelet Activity in a Changing Redox Environment. Antioxidants &amp; Redox Signaling, 20, 2074-2089. https://doi.org/10.1089/ars.2013.5698</mixed-citation></ref><ref id="scirp.102845-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Makarov, M.S., Borovkova, N.V. and Storozheva, M.V. (2017) Morphofunctional Properties of Human Platelets Treated with Silver Nanoparticles. Bulletin of Experimental Biology and Medicine, 164, 241-246. https://doi.org/10.1007/s10517-017-3966-9</mixed-citation></ref></ref-list></back></article>